nivolumabRP1Vusolimogene oderparepvecBRAFimelanomaanti-PD-1 therapy
…vec (RP1; an HSV-1-based oncolytic immunotherapy) combined with nivolumab demonstrated clinically meaningful, durable antitumor activity …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: BRAFi ×
BRAFi
This drug is selected. Its supporting articles are shown below.